Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial.
Shimozuma K, Ohashi Y, Takeuchi A, Aranishi T, Morita S, Kuroi K, Ohsumi S, Makino H, Katsumata N, Kuranami M, Suemasu K, Watanabe T, Hausheer FH. Shimozuma K, et al. Among authors: suemasu k. Support Care Cancer. 2012 Dec;20(12):3355-64. doi: 10.1007/s00520-012-1492-x. Epub 2012 May 15. Support Care Cancer. 2012. PMID: 22584733 Clinical Trial.
Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04).
Takei H, Ohsumi S, Shimozuma K, Takehara M, Suemasu K, Ohashi Y, Hozumi Y. Takei H, et al. Among authors: suemasu k. Breast Cancer Res Treat. 2012 May;133(1):227-36. doi: 10.1007/s10549-011-1943-y. Epub 2012 Jan 11. Breast Cancer Res Treat. 2012. PMID: 22234519 Clinical Trial.
Subjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: The National Surgical Adjuvant Study of Breast Cancer 02.
Ohsumi S, Shimozuma K, Ohashi Y, Takeuchi A, Suemasu K, Kuranami M, Ohno S, Watanabe T. Ohsumi S, et al. Among authors: suemasu k. Oncology. 2012;82(3):131-8. doi: 10.1159/000336480. Epub 2012 Mar 15. Oncology. 2012. PMID: 22433221 Clinical Trial.
Comparison of EQ-5D scores among anthracycline-containing regimens followed by taxane and taxane-only regimens for node-positive breast cancer patients after surgery: the N-SAS BC 02 trial.
Shiroiwa T, Fukuda T, Shimozuma K, Kuranami M, Suemasu K, Ohashi Y, Watanabe T. Shiroiwa T, et al. Among authors: suemasu k. Value Health. 2011 Jul-Aug;14(5):746-51. doi: 10.1016/j.jval.2011.01.007. Epub 2011 Jun 2. Value Health. 2011. PMID: 21839414 Free article. Clinical Trial.
The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-study.
Hozumi Y, Suemasu K, Takei H, Aihara T, Takehara M, Saito T, Ohsumi S, Masuda N, Ohashi Y. Hozumi Y, et al. Among authors: suemasu k. Ann Oncol. 2011 Aug;22(8):1777-82. doi: 10.1093/annonc/mdq707. Epub 2011 Feb 1. Ann Oncol. 2011. PMID: 21285133 Free article. Clinical Trial.
Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
Komoike Y, Akiyama F, Iino Y, Ikeda T, Akashi-Tanaka S, Ohsumi S, Kusama M, Sano M, Shin E, Suemasu K, Sonoo H, Taguchi T, Nishi T, Nishimura R, Haga S, Mise K, Kinoshita T, Murakami S, Yoshimoto M, Tsukuma H, Inaji H. Komoike Y, et al. Among authors: suemasu k. Cancer. 2006 Jan 1;106(1):35-41. doi: 10.1002/cncr.21551. Cancer. 2006. PMID: 16333848 Free article.
Long-term results of breast-conserving treatment for early-stage breast cancer in Japanese women from multicenter investigation.
Ohsumi S, Sakamoto G, Takashima S, Koyama H, Shin E, Suemasu K, Nishi T, Nakamura S, Iino Y, Iwase T, Ikeda T, Teramoto S, Fukutomi T, Komaki K, Sano M, Sugiyama K, Miyoshi K, Kamio T, Ogita M. Ohsumi S, et al. Among authors: suemasu k. Jpn J Clin Oncol. 2003 Feb;33(2):61-7. doi: 10.1093/jjco/hyg014. Jpn J Clin Oncol. 2003. PMID: 12629055
A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapy.
Ohsumi S, Nishimura R, Masuda N, Akashi-Tanaka S, Suemasu K, Yamauchi H, Tokunaga E, Ikeda T, Nishi T, Hayashi H, Iino Y, Takatsuka Y, Ohashi Y, Inaji H. Ohsumi S, et al. Among authors: suemasu k. Breast Cancer. 2023 Jan;30(1):131-138. doi: 10.1007/s12282-022-01406-5. Epub 2022 Sep 30. Breast Cancer. 2023. PMID: 36175750 Free PMC article.
Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors.
Komoike Y, Akiyama F, Iino Y, Ikeda T, Tanaka-Akashi S, Ohsumi S, Kusama M, Sano M, Shin E, Suemasu K, Sonoo H, Taguchi T, Nishi T, Nishimura R, Haga S, Mise K, Kinoshita T, Murakami S, Yoshimoto M, Tsukuma H, Inaji H. Komoike Y, et al. Among authors: suemasu k. Breast Cancer. 2005;12(2):104-11. doi: 10.2325/jbcs.12.104. Breast Cancer. 2005. PMID: 15858440 Free article.
262 results